Mesenchymal stem/stromal cell therapy in atopic dermatitis and chronic urticaria: immunological and clinical viewpoints-Reference-Cited by-同舟云学术

Mesenchymal stem/stromal cell therapy in atopic dermatitis and chronic urticaria: immunological and clinical viewpoints

Published:2021-10-11 Issue:1 Volume:12 Page:
ISSN:1757-6512
Container-title:Stem Cell Research & Therapy
language:en
Short-container-title:Stem Cell Res Ther

Author:

Kim Eun-Young,Kim Hyuk Soon,Hong Ki-Sung,Chung Hyung-Min,Park Se-Pill,Noh Geunwoong^ORCID

Abstract

AbstractAllergic diseases are immune-mediated diseases. Allergies share a common immunopathogenesis, with specific differences according to the specific disease. Mesenchymal stem/stromal cells (MSCs) have been applied to people suffering from allergic and many other diseases. In this review, the immunologic roles of MSCs are systemically reviewed according to disease immunopathogenesis from a clinical viewpoint. MSCs seem to be a promising therapeutic modality not only as symptomatic treatments but also as causative and even preventive treatments for allergic diseases, including atopic dermatitis and chronic urticaria.

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Biochemistry, Genetics and Molecular Biology (miscellaneous),Molecular Medicine,Medicine (miscellaneous)

Link

https://link.springer.com/content/pdf/10.1186/s13287-021-02583-4.pdf

Reference160 articles.

1. Li H, Tian Y, Xie L, Liu X, Huang Z, Su W. Mesenchymal stem cells in allergic disease: current status. Allergol Int. 2020;69:35–45.

2. Lancour M. Acute infections in atopic dermatitis. A clue for a pathogenic role of a Th1/Th2 imbalance. Dermatology. 1994;188:255–7.

3. Krampera M, Pasini A, Pizzolo G, Cosmi L, Romagnani S, Annunziato F. Regenerative and immunomodulatory potential of mesenchymal stem cells. Curr Opin Pharmacol. 2006;6:445–51.

4. Noh G, Lee SS. A pilot study of IFN-gamma-induced specific oral tolerance induction (ISOTI) for IgE-mediated anaphylactic food allergy. J Interferon Cytokine Res. 2009;29:667–75.

5. Kiely L, Bowe S, O’Connor C, Bennett M, Bourke J, Murphy M. Novel agents for atopic dermatitis in patients over 50 years of age: a case series. Dermatol Ther. 2021;34:e14890.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulatory effects of canine mesenchymal stem cells in an experimental atopic dermatitis model;Frontiers in Veterinary Science;2023-07-13

2. Introductory Chapter: Allergic Disease – New Developments in Diagnosis and Therapy;Allergic Disease - New Developments in Diagnosis and Therapy;2023-04-12

3. Extracellular vesicles from IFN-γ-primed mesenchymal stem cells repress atopic dermatitis in mice;Journal of Nanobiotechnology;2022-12-10

4. Dynamic change, influencing factors, and clinical impact of cellular components in human breast milk;Pediatric Research;2022-09-23

5. Mesenchymal stem cells and cell-free preparations for treating atopic dermatitis;BIOCELL;2022